Noteworthy

Dec 01, 2010
Pharmaceutical Executive
Pharm Exec's Pipeline Report 2014
Dec 01, 2010
Pharmaceutical Executive
Pharm Exec's Pipeline Report 2016
Dec 01, 2010
Pharmaceutical Executive
Cegedim survey documents whether European industry is ready for the challenge of new compliance and disclosure risks on promotional spend
Dec 01, 2010
Pharmaceutical Executive
The strict regulatory divide between market authorization and price reimbursement iscrumbling in the US. Is industry prepared to adapt or challenge?
Dec 01, 2010
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Pharma sets the pace for China's ambitious new innovation agenda
Dec 01, 2010
Pharmaceutical Executive
42 of the best new drugs in development–or parked at the FDA
Dec 01, 2010
Pharmaceutical Executive
Pharm Exec's Pipeline Report 2021
Dec 01, 2010
Pharmaceutical Executive
Pharm Exec's Pipeline Report 2019
Dec 01, 2010
Pharmaceutical Executive
Pharm Exec's Pipeline Report 2022
Dec 01, 2010
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Outgoing EMA Director Thomas Lonngren discusses a decade at the helm of Europe's top regulatory office
native1_300x100
lorem ipsum